---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-241840"
form_type: "8-K"
ticker: "CYTK"
cik: "0001061983"
company_name: "CYTOKINETICS INC"
filed_at: "2026-05-27T20:00:58+00:00"
generated_at: "2026-05-27T20:01:59.355391+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Cytokinetics shareholders re-elect three Class I directors and approve all four proposals at annual meeting

## Summary
- Edward M. Kaye, Wendell Wierenga, and Nancy J. Wysenski re-elected as Class I directors; Wierenga received 85.4M for vs 22.4M withheld.
- ESPP amendment approved to increase authorized shares by 1,000,000; 107.3M for, 261k against.
- Ernst & Young LLP ratified as auditor for FY 2026; 115.5M for, 269k against.
- Advisory vote on executive compensation passed with 104.0M for, 3.0M against.
- Quorum of 93.47% of eligible shares represented at meeting.

## SEC filing metadata
- accession: 0001193125-26-241840
- form_type: 8-K
- ticker: CYTK
- cik: 0001061983
- company_name: CYTOKINETICS INC
- filed_at: 2026-05-27T20:00:58+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1061983/000119312526241840/0001193125-26-241840-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1061983/000119312526241840/cytk-20260527.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-241840
- JSON: https://secwatch.observer/filing/0001193125-26-241840.json
- Plain text: https://secwatch.observer/filing/0001193125-26-241840.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.